Home Search

dbv - search results

If you're not happy with the results, please do another search
Viaskin Peanut

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

"This submission represents a significant step forward for those families living with peanut allergy."
DBV Patch Closeup

DBV Completes Phase III Study of Peanut Patch

0
The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.

Nestlé Partners with DBV to Develop Milk Allergy Test

0
The world's largest food business forays into allergy diagnostic services to help sell infant formula.
Hope

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

0
Explore the latest breakthroughs in food allergy research from 2025 that aim to prevent anaphylaxis and promote long-term immunity.
Research Lab

A new era in food allergy treatment has begun

0
Innovative treatments aim to do more than manage symptoms; they offer the potential for long-term remission and even a cure.
Viaskin Patch

Optimism Grows for Toddlers with Peanut Allergies as Viaskin Patch Safety Study Begins

0
DBV Technologies anticipates their submission to the FDA will occur in the second half of 2026
Viaskin Patch

Viaskin Patch Improves Treatment for Pediatric Milk Allergies

The patch releases small doses of a milk allergen protein through the skin without ingestion.
Viaskin Patch

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in Children

0
95.5% of the participants completed treatment, with most adverse effects being mild or moderate reactions at the application site.
Viaskin Patch

Skin Patch Immunotherapy Determined Safe and Effective in Toddlers With Peanut Allergy

0
According to research presented at this year's #ACAAI22 meeting.